Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Learn how to use your skills to earn money that can lead to debt freedom. Turn your talents into financial gains.
16,412 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Investors are watching codexis (CDXS) 2025 earnings closely to see if partnerships and enzyme platforms translate int...
Understanding runway growth (rway) earnings helps you assess whether a young company can sustain momentum. Learn key ...
Fidelis Investors closes a $144 million RTL securitization, its third, backing 330 rehab loans across 29 lenders. The...
Thinking about investing in artificial intelligence stocks hold for the long run? This article breaks down two depend...
Costco combines a members-only model with scale and efficiency. This article examines the odds that will costco whole...
WM Technology MAPS is weighing a pivotal year. This guide breaks down the Q4 2025 earnings, what technology (maps) 20...
When a mining stock slumps, it usually signals a mix of precious metal prices, costs, and market sentiment. This piec...
Sunoco LP is redefining its business, shifting from fueling pumps to a broader energy platform. With 2026 EBITDA guid...
When a beloved fantasy IP meets a streaming giant, the financial narrative changes as quickly as a plot twist. This a...
Lenders posted healthier profits per loan in Q3 2025, but declined loans still drain resources. A new declined loan a...
SkyWater Technology just posted a record revenue figure, but the CFO sold about $2.5 million worth of stock. This art...